Related Experiment Video
Updated: Apr 24, 2026

02:22
Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection
Published on: April 12, 2024
1.3K
Goldenhar syndrome - a case report
M Mutanabbi1, M A Rahman, A A Mamun
1Dr Mahbub Mutanabbi, Associate Professor, Department of Pediatrics, Bangabandhu Sheikh Mujib Medical University (BSMMU), Shahbagh, Dhaka, Bangladesh.
Mymensingh Medical Journal : MMJ
|September 3, 2014
Summary
Goldenhar syndrome, a rare condition affecting craniofacial development, presents with ocular, auricular, and vertebral abnormalities. This case highlights a multidisciplinary approach for managing a 10-year-old girl with these features.
Area of Science:
- Developmental biology
- Genetics
- Ophthalmology
- Otolaryngology
- Orthopedics
Background:
- Goldenhar syndrome, also known as hemifacial microsomia, is a congenital disorder characterized by underdevelopment of the first and second branchial arches.
- It involves craniofacial, ocular, and vertebral abnormalities, with sporadic occurrence being more common than familial inheritance (autosomal dominant or recessive patterns).
- Potential teratogenic influences from toxic substances are also considered contributing factors.
Observation:
- A 10-year-old girl presented with clinical manifestations consistent with Goldenhar syndrome.
- Key features included ocular abnormalities (epibulbar dermoid, lipodermoid, coloboma), otic defects (preauricular tags, microtia, anotia, conductive hearing loss), and vertebral anomalies.
- Associated cardio-pulmonary and genitourinary abnormalities are common in Goldenhar syndrome, though not explicitly detailed for this patient in the abstract.
Findings:
- The patient exhibited a constellation of ocular, auricular, and vertebral changes indicative of Goldenhar syndrome.
- A multidisciplinary management approach was implemented for the patient.
- The patient showed symptomatic improvement following the initial management.
Implications:
- This case underscores the importance of a comprehensive, multidisciplinary approach in managing patients with Goldenhar syndrome.
- While symptomatic improvement was achieved, corrective surgical interventions remain a planned component of long-term care.
- Further research into the genetic and environmental factors contributing to Goldenhar syndrome can aid in early diagnosis and targeted interventions.
More Related Videos
Related Concept Videos
Huntington Disease l: Introduction
53
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show...
53
Lethal Alleles
11.3K
Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
11.3K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
801
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
801
Inborn Errors of Metabolism
1.1K
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.1K
Cushing Syndrome I: Introduction
20
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the...
20

